| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |